Evolving Management of Paroxysmal Sympathetic Hyperactivity Our understanding and management of paroxysmal sympathetic hyperactivity (PSH) has evolved significantly over the years, yet challenges persist. Initially, PSH was often misdiagnosed or overlooked due to its overlap with other conditions. However, advancements in neurological imaging and clinical observation have improved detection rates. Drawing from personal experience as a nurse, I've witnessed the importance of early recognition and prompt intervention in managing PSH episodes. While pharmacological approaches like beta-blockers and anticonvulsants are commonly utilized, individual responses vary, necessitating tailored treatment plans. Healthcare professionals play a vital role in educating caregivers on recognizing triggers and implementing non-pharmacological interventions such as positioning and environmental modifications. Ensuring continuous support for caregivers is crucial as they navigate the unpredictable nature of neurostorming episodes. Additionally, a multidisciplinary approach involving neurologists, nurses, therapists, and social workers is essential for holistic patient care and long-term management. Despite these advancements, challenges remain in optimizing treatment efficacy and addressing the psychosocial impact on patients and caregivers. Continued research and collaboration within the healthcare community are imperative to further enhance our understanding and management of PSH.